This Critical Care Awareness Month, ICU Teams Deserve More Thanks Than Ever

This Critical Care Awareness Month, ICU Teams Deserve More Thanks Than Ever

From states of emergency to natural disasters, to a pandemic that turned the world upside down, the last year has been one of truly extraordinary challenges. In the wake of these events, healthcare providers in the intensive care unit (ICU) have displayed extraordinary perseverance and heroism.  

As we recognize Critical Care Awareness and Recognition Month, our NxStage Critical Care team wants our nation’s ICU nephrologists, nurses, biomedical teams, and intensivists to know that we appreciate the dedication, skill, and compassion it takes to deliver superior care to the most critical patients.

As a provider of critical care equipment and technology, NxStage Critical Care has seen, heard, and felt the stories of sacrifice and selflessness throughout this unprecedented year. We know the hours, workload, and number of sick kept rising, even as those on the front lines desperately needed those figures to fall. We realize that ICUs were often understaffed, underequipped, and overwhelmed during this time, and many gave up being near family, friends, and loved ones to prioritize the patients entrusted to their care.1

Even in times of relative normalcy, there is still work to be done and preparations to be made, because the next critical event could come at any time. In the ICU, caring and preparing is a constant.

In the video below, NxStage Critical Care expresses its heartfelt gratitude to ICU teams across the U.S. for the heroism displayed throughout the COVID-19 pandemic.

Video Player

00:00

03:08

INDICATIONS FOR USE:
The NxStage® System OneTM is indicated for the treatment of acute and chronic renal failure, or fluid overload using hemofiltration, hemodialysis, and/or ultrafiltration, in an acute or chronic care facility. The NxStage System One is also indicated for Therapeutic Plasma Exchange in a clinical environment. All treatments must be administered under a physician’s prescription, and must be observed by a trained and qualified person, considered to be competent in the use of this device by the prescribing physician. NxView is a computer-based touch screen user interface that provides online instructions for use, summarized system information, and remote access. NxView TM is contraindicated as the sole method of monitoring a patient during treatment.2

RISK INFORMATION:
Renal replacement therapy, as with any medical therapy, is not without risks. The decision of which therapy to use should be made by the physician, based on previous experience and on the individual facts and circumstances of the patient. There is no literature demonstrating one therapy is clinically better than another.3

1. Michael S. Anger, Claudy Mullon, Linda H. Ficociello, David Thompson, Michael A. Kraus, Pete Newcomb, and Robert J. Kossmann, Kidney360, February 2021, 2 (2) 350-354, https://kidney360.asnjournals.org/content/2/2/350

2. NxStage System One User Guide, NC4921 Rev. H 2020-01.

3. Kraus MA. Selection of Dialysate and Replacement Fluids and Management of Electrolyte and Acid-Base Disturbances. Seminars in Dialysis; Vol 22, No 2 (March-April) 2009 pp. 137-140.

CAUTION: Federal law restricts this device to sale by or on the order of a physician.

© 2021 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, NxStage, NxView, and System One are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners.
P/N 104735-01 Rev A 05/2021 / APM3428 Rev A